Skip to main content
Mansur Shomali, MD, Endocrinology, Baltimore, MD

Mansur E. Shomali MD

Diabetes, Lipid Metabolism


Program Director, Endocrinology Fellowship, Union Memorial Hospital, Baltimore, Maryland

Join to View Full Profile
  • 200 E 33rd St# 33Baltimore, MD 21218

  • Phone+1 410-554-4511

  • Fax+1 410-554-6490

Dr. Shomali is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Maryland
    University of MarylandResidency, Internal Medicine, 2007
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2000
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 1994 - 1997
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1994

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2002 - 2025
  • MA State Medical License
    MA State Medical License 1999 - 2004
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Lectures

  • Hypoglycemia Prediction Using SMBG Data and Patient Medication Information 
    Baltimore, MD - 6/16/2014

Press Mentions

  • DC Doctor Encouraged by Advances in Therapies That Treat Diabetes
    DC Doctor Encouraged by Advances in Therapies That Treat DiabetesNovember 9th, 2022
  • Welldoc's Bluestar Lands FDA Clearance for Expanded Insulin Dosing Support
    Welldoc's Bluestar Lands FDA Clearance for Expanded Insulin Dosing SupportSeptember 22nd, 2021
  • Welldoc Submits 510(K) for Long-Acting Insulin Support for Their Award-Winning Digital Health Solution BlueStar®
    Welldoc Submits 510(K) for Long-Acting Insulin Support for Their Award-Winning Digital Health Solution BlueStar®January 16th, 2020
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: